PFD report

James Stuart Atkinson · Prevention of Future Deaths report

Pin Get email alerts Request correction

Issued 26 Jan 2024•Newcastle and North Tyneside

Report record

Published report and response evidence

This page connects the concerns raised in this report with statements found in recipients’ published responses. A link shows a clear evidence connection; it does not assign responsibility.

View original report
Concerns
2

Raised in this report

Recipients
3

Named on the report

Responses found
2

Of 3 recipients

Stated actions
3

Described in responses

Source document

Full report text

This is the full text from the original published report.

Open published report

Concerns and recipient responses

Select any concern, action or position to view the source wording.

Report evidence summary

Concerns raised2

  1. Lack of an appropriate structure to educate and manage people diagnosed with allergies and anaphylaxis
    Part of recurring concern: Inadequate anaphylaxis safety education for patients, parents and schools
  2. Failure to provide regular review of allergy, anaphylaxis risk and the benefits of automatic adrenaline injectors
Responses linked to these concerns

Each statement is shown once, even when linked to more than one concern.

Actions described in response An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.1

  1. Action

    Review and update the Specialist Allergy Service Specification, including stronger transition, self-care, information and personal management plan requirements.

    Stated by NHS EnglandStated in progressThe respondent said that this action was in progress when they made their response on 12 February 2024.

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Lack of an appropriate structure to educate and manage people diagnosed with allergies and anaphylaxis

Wider context from the report

“The evidence in this case unequivocally established that James was not under regular review for his allergy, risk of anaphylaxis and the benefits of automatic adrenaline injectors. The report of ████████ (attached) identifies the need for wider consideration of a systematic approach to improving anaphylaxis awareness and management. The risk of future deaths in the context of allergy/anaphylaxis remains in the absence of an appropriate structure to educate, review and manage those who are diagnosed allergies. ”

Is this part of a recurring concern?

Yes — Inadequate anaphylaxis safety education for patients, parents and schools.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Failure to provide regular review of allergy, anaphylaxis risk and the benefits of automatic adrenaline injectors

Wider context from the report

“The evidence in this case unequivocally established that James was not under regular review for his allergy, risk of anaphylaxis and the benefits of automatic adrenaline injectors. The report of ████████ (attached) identifies the need for wider consideration of a systematic approach to improving anaphylaxis awareness and management. The risk of future deaths in the context of allergy/anaphylaxis remains in the absence of an appropriate structure to educate, review and manage those who are diagnosed allergies. ”

Is this part of a recurring concern?

No recurring-concern membership is currently published.

Open source report

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Review and update the Specialist Allergy Service Specification, including stronger transition, self-care, information and personal management plan requirements.

Verbatim wording from the response

“NHS England has a Clinical Reference Group (CRG) that provides clinical advice and leadership for both Specialised Immunology and Specialised Allergy services. The membership includes clinicians, commissioners, public health experts and Patient and Public Voice members. They use their combined knowledge and expertise to advise NHS England on the optimal arrangements for the commissioning of specialised services. This includes developing national standards for services delivering specialised care to patients with allergies in the form of national service specifications and policies. The CRG commenced a review of the current published Specialist Allergy Service Specification in May 2023, which is expected to be complete by Summer 2024.”

Source location

Response from NHS England
Page 1 · response
Published 12 February 2024

Open published response

Other statements in published responses

These actions and other statements could not be clearly connected to one concern in this report.

Recipient-stated actions An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.2

  1. 1

    Discuss all Prevention of Future Deaths reports through the Regulation 28 Working Group to share learning and identify emerging safety trends requiring review or action.

    Stated by NHS EnglandStated completedThe respondent said that this action was complete when they made their response on 12 February 2024.
  2. 2

    Share national guidance and resources on the safe use of adrenaline auto-injectors with relevant healthcare professionals.

    Stated by NHS EnglandStated completedThe respondent said that this action was complete when they made their response on 12 February 2024.

Recipient positions A position is what a recipient says about a concern when they do not describe a specific action.1

  1. 1

    The relevance of NICE anaphylaxis guidance is unclear because it is unknown whether James had previously experienced anaphylaxis.

    Stated by Department of Health and Social CareDisputes the concernThe respondent disagreed with part of the concern or the basis for it.

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Discuss all Prevention of Future Deaths reports through the Regulation 28 Working Group to share learning and identify emerging safety trends requiring review or action.

Verbatim wording from the response

“I would also like to provide further assurances on national NHS England work taking place around the Reports to Prevent Future Deaths. All reports received are discussed by the Regulation 28 Working Group, comprising Regional Medical Directors, and other clinical and quality colleagues from across the regions. This ensures that key learnings and insights around preventable deaths are shared across the NHS at both a national and regional level and helps us pay close attention to any emerging trends that may require further review and action.”

Source location

Response from NHS England
Page 2 · response
Published 12 February 2024

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Share national guidance and resources on the safe use of adrenaline auto-injectors with relevant healthcare professionals.

Verbatim wording from the response

“The following links to guidance were also shared by NHS England’s North East and Yorkshire Regional Chief Pharmacist to reinforce guidance and learning:”

Source location

Response from NHS England
Page 2 · response
Published 12 February 2024

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

The relevance of NICE anaphylaxis guidance is unclear because it is unknown whether James had previously experienced anaphylaxis.

Verbatim wording from the response

“NICE has published a clinical guideline, Anaphylaxis: assessment and referral after emergency treatment (CG134), and a quality standard on anaphylaxis (QS119). Both this guideline and quality standard cover care after emergency treatment for suspected anaphylaxis, including assessment and referral to specialist allergy services. That is, they begin at the point in the clinical pathway immediately after a health professional has started to manage a suspected anaphylactic reaction.”

Source location

Response from Department of Health and Social Care
Page 2 · response
Published 12 February 2024

Open published response
Back to top

Information checked against the published report and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Official responses located
2/3

Data last updated 7 September 2026